Literature DB >> 21283026

Extraocular muscle enlargement as a paraneoplastic effect of breast carcinoma in a male patient.

Purnima Mehta1, Swaroop Chickadasarahally, Nicholas Hedley, Harpreet Ahluwalia.   

Abstract

The authors report a rare case of a male patient who was diagnosed with breast cancer following investigations for proptosis secondary to extraocular muscle enlargement. A 65-year-old man presented with complaints of double vision and proptosis. CT scan of the orbits showed bilateral superior rectus muscle enlargement. On further investigation, the patient was detected to have a right breast mass. Biopsy of the mass showed an intermediate-grade carcinoma in situ. The patient underwent a right radical mastectomy following which his proptosis and symptoms of double vision resolved. Repeat MRI scans showed reduction in the size of the superior rectus muscle after mastectomy. Extraocular muscle enlargement has not been previously identified as a paraneoplastic effect of breast carcinoma in a male patient. Extraocular muscle enlargement can be a presenting feature of malignancies, and an appropriate systemic workup for the occult primary when all other preliminary tests are negative should be considered.

Entities:  

Mesh:

Year:  2011        PMID: 21283026     DOI: 10.1097/IOP.0b013e3182078e31

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  The enlarged extraocular muscle: to relax, reflect or refer?

Authors:  F Shafi; P Mathewson; P Mehta; H S Ahluwalia
Journal:  Eye (Lond)       Date:  2016-12-02       Impact factor: 3.775

2.  Pleomorphic Carcinoma with Exophthalmos and a Subsequent Diagnosis of Paraneoplastic Syndrome.

Authors:  Yutaro Kuzunishi; Akifumi Tsuzuku; Fumihiro Asano; Yui Sasaki; Rina Matsuno; Mayuka Taguchi; Yuya Muto; Masaaki Tsuchida; Yasutomo Baba; Tomoya Kato; Anri Murakami; Atsunori Masuda; Hisashi Daido; Shinsuke Matsumoto
Journal:  Intern Med       Date:  2020-09-30       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.